Evidence map›Paper›PMID 19078974›Full record

ReviewNature reviews. Cancer2009

Tetraspanins: push and pull in suppressing and promoting metastasis.

Margot Zöller

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 362 papers.

0numbers the graph read from it
0cells of the map it votes in
362citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

362 citing papers in PubMed, 650 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. CD151 interacts with integrin beta 2 in B cell lymphomas.Cellular and molecular life sciences : CMLS · 2025
    Article
  18. Review
  19. Article
  20. Review

302 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Margot ZöllerDepartment of Tumour Cell Biology, University Hospital of Surgery, Heidelberg, Germany. m.zoeller@dkfz.de
National Center for Tumor Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumours progress through a cascade of events that enable the formation of metastases. Some of the components that are required for this fatal process are well established. Tetraspanins, however, have only recently received attention as both metastasis suppressors and metastasis promoters. This late appreciation is probably due to their capacity to associate with various molecules, which they recruit into special membrane microdomains, and their abundant presence in tumour-derived small vesicles that aid intercellular communication. It is reasonable to assume that differences in the membrane and vesicular web components that associate with individual tetraspanins account for their differing abilities to promote and suppress metastasis.

Indexed as

AnimalsAntigens, CDAntigens, NeoplasmCell CommunicationCell MovementDisease ProgressionExosomesHumansIntegrinsKangai-1 ProteinMembrane GlycoproteinsMembrane MicrodomainsMembrane ProteinsMultigene FamilyNeoplasm MetastasisNeoplasm ProteinsAntigens, CDAntigens, NeoplasmCD151 protein, humanCD9 protein, humanIntegrinsKangai-1 ProteinMembrane GlycoproteinsMembrane ProteinsNeoplasm ProteinsTetraspanin 24Tetraspanin 29TetraspaninsTSPAN8 protein, human

Identifiers

PMID19078974
OpenAlexW1984109999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.